{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:55:17Z","timestamp":1783468517586,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,8,12]],"date-time":"2012-08-12T00:00:00Z","timestamp":1344729600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00296-012-2464-7","type":"journal-article","created":{"date-parts":[[2012,8,11]],"date-time":"2012-08-11T01:15:13Z","timestamp":1344647713000},"page":"1021-1025","source":"Crossref","is-referenced-by-count":14,"title":["Primary Sj\u00f6gren\u2019s syndrome and B-non-Hodgkin lymphoma: role of CD4+ T lymphocytopenia"],"prefix":"10.1007","volume":"33","author":[{"given":"Faten","family":"Ismail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Abdelhaleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amro","family":"Mamdoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Geneidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enas","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,12]]},"reference":[{"issue":"1","key":"2464_CR1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/art.24150","volume":"60","author":"S Hu","year":"2009","unstructured":"Hu S, Zhou M, Jiang J, Wang J, Elashoff D, Gorr S et al (2009) Biology analysis of Sj\u00f6gren\u2019s syndrome and MALT lymphoma development in parotid glands. Arthritis Rheum 60(1):81\u201392","journal-title":"Arthritis Rheum"},{"issue":"10","key":"2464_CR2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ncprheum0620","volume":"3","author":"A Hansen","year":"2007","unstructured":"Hansen A, Lipsky PE, D\u00f6rner T (2007) B-cell lymphoproliferation in chronic inflammatory rheumatic diseases. Nat Clin Pract Rheumatol 3(10):561\u2013569","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"4","key":"2464_CR3","first-page":"559","volume":"59","author":"M Prochorec-Sobieszek","year":"2005","unstructured":"Prochorec-Sobieszek M, Wagner T (2005) Lymphoproliferative disorders in Sj\u00f6gren\u2019s syndrome. Otolaryngol Pol 59(4):559\u2013564","journal-title":"Otolaryngol Pol"},{"issue":"8","key":"2464_CR4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/ard.2005.046193","volume":"56","author":"M Voulgarelis","year":"2006","unstructured":"Voulgarelis M, Giannouli S, Tzioufas AG, Moutsopoulos HM (2006) Long term remission of Sj\u00f6gren\u2019s syndrome associated aggressive B cell non Hodgkin\u2019s lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone). Ann Rheum Dis 56(8):1033\u20131037","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2464_CR5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/toxsci\/kfm246","volume":"103","author":"SK Ramiah","year":"2008","unstructured":"Ramiah SK, Rittling S (2008) Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer. Toxicol Sci 103(1):4\u201313","journal-title":"Toxicol Sci"},{"issue":"4","key":"2464_CR6","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/art.20176","volume":"50","author":"E Theander","year":"2004","unstructured":"Theander E, Manthorpe R, Jacobsson LTH (2004) Mortality and causes of death in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheum 50(4):1262\u20131269","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2464_CR7","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","volume":"65","author":"E Theander","year":"2006","unstructured":"Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LTH (2006) Lymphoma and other malignancies in primary Sj\u00f6gren\u2019s syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 65(6):796\u2013803","journal-title":"Ann Rheum Dis"},{"key":"2464_CR8","volume-title":"World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissue","year":"2001","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) (2001) World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissue. IARC Press, Lyon"},{"issue":"6","key":"2464_CR9","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) European Study Group on classification criteria for Sj\u00f6gren\u2019s syndrome. Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American\u2013European consensus group. Ann Rheum Dis 61(6):554\u2013558","journal-title":"Ann Rheum Dis"},{"key":"2464_CR10","unstructured":"Mark P, Diego V (2009) Basic and clinical immunology Churchill livingstone, 2nd edn (11 Mar). ISBN-19:978-0443100826: assessing immune function: detection of serum levels of immunoglobulin, complement and other immune mediators, pp 270\u2013271"},{"key":"2464_CR11","unstructured":"Mark P, Diego V (2009) Basic and clinical immunology Churchill livingstone, 2nd edn (11 Mar). ISBN 12-978-0443100826 immunofluorescence; rheumatic diseases, pp 172\u2013173"},{"key":"2464_CR12","unstructured":"Gorevic PD, Galanakis (2002) Cryoglobulins, cryofibrinogenemia, and pyroglobulins. In: Rose NR, Hamilion RG, Detrick B (eds) Manual of clinical laboratory immunology. ASM Press, Washington, p 97"},{"key":"2464_CR13","unstructured":"Shaw S, Ginther-Lure G, Lksw G (1993) Antibodies and molecules of the 5th international workshop of leukocytes differentiation antigens. In: Leukocyte typing V: white cell differentiation antigens. Oxford University Press, Oxford"},{"issue":"2","key":"2464_CR14","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1186\/ar2182","volume":"9","author":"W Peter","year":"2007","unstructured":"Peter W, Markus G, Schotte H, Maaser C, Domschke W, Schl\u00fcter B et al (2007) Increased serum levels of macrophage migration inhibitory factor in patients with primary Sj\u00f6gren\u2019s syndrome. Arthritis Res Ther 9(2):R43","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"2464_CR15","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","volume":"42","author":"M Voulgarelis","year":"1999","unstructured":"Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM (1999) Malignant lymphoma in primary Sj\u00f6gren\u2019s syndrome a multicenter, retrospective, clinical study by the European Concerted Action on Sj\u00f6gren\u2019s syndrome. Arthritis Rheum 42(8):1765\u20131772","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2464_CR16","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","volume":"46","author":"JP Ioannidis","year":"2002","unstructured":"Ioannidis JP, Vassiliou VA, Moutsopoulos HM (2002) Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheum 46(3):741\u2013747","journal-title":"Arthritis Rheum"},{"key":"2464_CR17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/rheumatology\/keh407","volume":"44","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals M, Brito-Zeron P, Yague J, Akasbi M, Bautista R, Ruano M et al (2005) Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford) 44:89\u201394","journal-title":"Rheumatology (Oxford)"},{"issue":"39","key":"2464_CR18","first-page":"2786","volume":"89","author":"N Jia","year":"2009","unstructured":"Jia N, Tang FL (2009) Characteristics of patients with primary Sj\u00f6gren\u2019s syndrome and non-Hodgkin\u2019s lymphoma: analysis of 9 cases. Zhonghua Yi Xue Za Zhi 89(39):2786\u20132788","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"39","key":"2464_CR19","first-page":"2773","volume":"90","author":"L Wang","year":"2010","unstructured":"Wang L, Zhao Y, Zhang FC (2010) Malignant lymphoma associated with primary Sj\u00f6gren\u2019s syndrome. Zhonghua Yi Xue Za Zhi 90(39):2773\u20132775","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"3","key":"2464_CR20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1157\/13115353","volume":"130","author":"MR Casals","year":"2008","unstructured":"Casals MR, Zeron PB (2008) Prognosis of patients with primary Sj\u00f6gren\u2019s syndrome. Med Clin (Barc) 130(3):109\u2013115","journal-title":"Med Clin (Barc)"},{"key":"2464_CR21","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/ard.60.11.1007","volume":"60","author":"X Martiette","year":"2001","unstructured":"Martiette X (2001) Lymphomas complicating Sjogrens syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells. Ann Rheum Dis 60:1007\u20131010","journal-title":"Ann Rheum Dis"},{"key":"2464_CR22","unstructured":"Salem A (2009) Prevalence of HCV among Yemeni patients with non-Hodgkin\u2019s lymphoma at AI-Thawra teaching hospital. Gulf J Oncol Jan(5):22\u20139"},{"issue":"4","key":"2464_CR23","first-page":"726","volume":"31","author":"T Mandl","year":"2004","unstructured":"Mandl T, Bredberg A, Jacobsson LT, Manthorpe R, Henriksson G (2004) CD4+ T-lymphocytopenia\u2014a frequent finding in anti-SSA antibody seropositive patients with primary Sj\u00f6gren\u2019s syndrome. J Rheumatol 31(4):726\u2013728","journal-title":"J Rheumatol"},{"issue":"8","key":"2464_CR24","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/1529-0131(199908)42:8<1673::AID-ANR16>3.0.CO;2-1","volume":"42","author":"M Zeher","year":"1999","unstructured":"Zeher M, Szodoray P, Gyimesi E, Szondy Z (1999) Correlation of increased susceptibility to apoptosis of CD4+ T cells with lymphocyte activation and activity of disease in patients with primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheum 42(8):1673\u20131681","journal-title":"Arthritis Rheum"},{"key":"2464_CR25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/rheumatology\/39.2.142","volume":"39","author":"G Henriksson","year":"2000","unstructured":"Henriksson G, Manthorpe R, Bredberg A (2000) Antibodies to CD4 in primary Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford) 39:142\u2013147","journal-title":"Rheumatology (Oxford)"},{"key":"2464_CR26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","volume":"4","author":"LS Young","year":"2004","unstructured":"Young LS, Rickinson AB (2004) Epstein\u2013Barr virus: 40\u00a0years on. Nat Rev Cancer 4:757\u2013768","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"2464_CR27","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1002\/art.20463","volume":"50","author":"A Triantafyllopoulou","year":"2004","unstructured":"Triantafyllopoulou A, Tapinos N, Moutsopoulos HM (2004) Evidence for coxsackievirus infection in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheum 50(9):2897\u20132902","journal-title":"Arthritis Rheum"},{"key":"2464_CR28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0065-230X(03)87298-6","volume":"87","author":"\u00c9 Rajnav\u00f6lgyi","year":"2003","unstructured":"Rajnav\u00f6lgyi \u00c9, L\u00e1ny \u00c0 (2003) Role of CD4+ T lymphocytes in antitumor immunity. Adv Cancer Res 87:195\u2013249","journal-title":"Adv Cancer Res"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2464-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-012-2464-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2464-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:21:39Z","timestamp":1559042499000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-012-2464-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,12]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["2464"],"URL":"https:\/\/doi.org\/10.1007\/s00296-012-2464-7","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,12]]}}}